- Home
- ALXO vs ORMP Comparison
ALXO vs ORMP Comparison
Compare ALXO & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- ORMP
- Stock Information
- Founded
- ALXO 2015
- ORMP 2002
- Country
- ALXO United States
- ORMP United States
- Employees
- ALXO N/A
- ORMP N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- ALXO Health Care
- ORMP Health Care
- Exchange
- ALXO Nasdaq
- ORMP Nasdaq
- Market Cap
- ALXO 76.5M
- ORMP 84.3M
- IPO Year
- ALXO 2020
- ORMP N/A
- Fundamental
- Price
- ALXO $0.55
- ORMP $2.15
- Analyst Decision
- ALXO Strong Buy
- ORMP Hold
- Analyst Count
- ALXO 6
- ORMP 1
- Target Price
- ALXO $4.14
- ORMP N/A
- AVG Volume (30 Days)
- ALXO 529.8K
- ORMP 76.8K
- Earning Date
- ALXO 05-08-2025
- ORMP 05-08-2025
- Dividend Yield
- ALXO N/A
- ORMP N/A
- EPS Growth
- ALXO N/A
- ORMP N/A
- EPS
- ALXO N/A
- ORMP N/A
- Revenue
- ALXO N/A
- ORMP N/A
- Revenue This Year
- ALXO N/A
- ORMP N/A
- Revenue Next Year
- ALXO N/A
- ORMP N/A
- P/E Ratio
- ALXO N/A
- ORMP N/A
- Revenue Growth
- ALXO N/A
- ORMP N/A
- 52 Week Low
- ALXO $0.46
- ORMP $1.82
- 52 Week High
- ALXO $17.83
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- ALXO 37.26
- ORMP 45.31
- Support Level
- ALXO $0.46
- ORMP $2.14
- Resistance Level
- ALXO $0.63
- ORMP $2.30
- Average True Range (ATR)
- ALXO 0.06
- ORMP 0.14
- MACD
- ALXO 0.02
- ORMP 0.01
- Stochastic Oscillator
- ALXO 42.86
- ORMP 60.00
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.